Biocon Shares Jump 5.95% In Early Trade

Mumbai, July 14: Biocon Ltd shares are up 5.95% at ₹432.75 as of 9:45 AM on July 14, 2026. The stock is trading in the upper third of its 52-week range, closer to the high than the low. 

A 3.3% band comes with unusually early participation. 

Biocon opened at ₹427.35 and has traded between an intraday low of ₹422.20 and a high of ₹436.15 so far. That represents a trading band of about 3.3% between the session’s high and low. 

About 1.36 crore shares have changed hands, compared with a full-day average of about 35.33 lakh. The stock has already traded about 3.8 times its full-day average volume with the session still open. 

The move has come without a fresh company announcement so far today. It also stands apart from the wider market picture, with NIFTY Pharma up 0.82% while the NIFTY 50 is down 0.56%. 

FAQs 

What does Biocon’s upper-third position leave to watch? 

The current price is about 2% below the 52-week high of ₹440.40 and about 31% above the 52-week low of ₹331. This places the stock near the upper end of its annual range, although it remains below the high. 

That proximity is a concrete intraday caution: a move near an annual high can encounter selling before the session ends, and a single-session gain can narrow while trading remains open. The day’s outcome is not yet final. 

Biocon carries a market value of about ₹70,266 crore. 

The pharmaceutical company trades at a TTM PE of 180.62, with TTM EPS of ₹2.82. 

For the rest of the July 14 session, the immediate monitorable is whether Biocon remains within its early trading band or tests either boundary as participation develops. The final price and volume picture will only be established when the live session ends. 

Frequently Asked Questions (FAQs) 

Why is Biocon’s share price up today? 

Biocon shares are up 5.95% at ₹432.75 in trade on July 14, 2026. There is no fresh company announcement so far today that establishes a reason for the intraday move. 

Where is Biocon trading relative to its 52-week range? 

On July 14, 2026, Biocon is trading in the upper third of its 52-week range, closer to the high than the low. At ₹432.75, it is about 2% below the 52-week high of ₹440.40 and about 31% above the low of ₹331. 

What is notable about Biocon’s trading volume today? 

About 1.36 crore Biocon shares have traded by 9:45 AM on July 14, 2026. That is already about 3.8 times the full-day average volume of about 35.33 lakh shares, even though the session remains open. 

What are Biocon’s current valuation figures? 

On July 14, 2026, Biocon has a market capitalisation of about ₹70,266 crore. The stock trades at a TTM PE of 180.62, with TTM EPS of ₹2.82. 

Key takeaways 

• Price: BIOCON is up 5.95% at ₹432.75 in early trade.
• Annual range: The stock is about 2% below its 52-week high.
• Participation: About 1.36 crore shares have traded, already around 3.8 times the full-day average.
• Market backdrop: The stock is outperforming both NIFTY Pharma and the NIFTY 50 so far today.

Source:

• https://www.nseindia.com/get-quotes/equity?symbol=BIOCON
• https://nsearchives.nseindia.com/corporate/BIOCON_13072026204142_Coveringletter.pdf